Beijing Konruns Pharmaceutical Co.,Ltd.’s Net Profit Dropped 10.2% in First Half of 2022

Beijing Konruns Pharmaceutical Co.,Ltd. (北京康辰药业股份有限公司) (603590.SH) reported a net profit of 89.8 million yuan in the first half of 2022, down 10.2% year-on-year.

Meanwhile, the company posted 371.6 million yuan in revenue, down 18.4% year-on-year.

At the end of the reporting period, it had 3.3 billion yuan in total assets and 197.3 million yuan in total liabilities, with a liability-to-asset ratio of 5.9%.